Corcept Therapeutics IncorporatedCORTNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank13
3Y CAGR-44.8%
5Y CAGR-25.8%
Year-over-Year Change
Year-over-year total asset growth rate
3Y CAGR
-44.8%/yr
vs -6.4%/yr prior
5Y CAGR
-25.8%/yr
Recent deceleration
Acceleration
-38.4pp
Decelerating
Percentile
P13
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 1.58% |
| Q3 2025 | 2.73% |
| Q2 2025 | -5.28% |
| Q1 2025 | 0.70% |
| Q4 2024 | 7.18% |
| Q3 2024 | 9.75% |
| Q2 2024 | 8.94% |
| Q1 2024 | 5.54% |
| Q4 2023 | 4.63% |
| Q3 2023 | 13.23% |
| Q2 2023 | -15.09% |
| Q1 2023 | 5.90% |
| Q4 2022 | 9.41% |
| Q3 2022 | 7.43% |
| Q2 2022 | 6.03% |
| Q1 2022 | 10.47% |
| Q4 2021 | -27.61% |
| Q3 2021 | 2.98% |
| Q2 2021 | 2.91% |
| Q1 2021 | -3.38% |
| Q4 2020 | 7.04% |
| Q3 2020 | 7.29% |
| Q2 2020 | 11.75% |
| Q1 2020 | 8.05% |
| Q4 2019 | 12.34% |
| Q3 2019 | 11.67% |
| Q2 2019 | 2.64% |
| Q1 2019 | 2.73% |
| Q4 2018 | 3.98% |
| Q3 2018 | 9.25% |
| Q2 2018 | 12.93% |
| Q1 2018 | 10.17% |
| Q4 2017 | 99.27% |
| Q3 2017 | 27.89% |
| Q2 2017 | 14.86% |
| Q1 2017 | 9.58% |
| Q4 2016 | 9.25% |
| Q3 2016 | 10.72% |
| Q2 2016 | 7.42% |
| Q1 2016 | 1.88% |